Wilmington, DE, United States of America

Suzanne J Suchard

This inventor holds 25 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Immunotherapy Development. Top assignees: Bristol-Myers Squibb Compnay, Domantis Limited, Astrazeneca Ab. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzanne J Suchard. Retrieved from https://idiyas.com/inventor/suzanne-j-suchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 8)

% Patents Active = 88.0

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 6.9

ph-index = 8

Forward Citations = 134(Granted Patents)

Location History:

Wilmington, DE (US) (2005 - 2021)
Portland, OR (US) (2020 - 2024)

Company Filing History:

22 out of 3,745

Bristol-Myers Squibb Compnay

Bristol Meyers Squibb Company

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

Areas of Expertise:

CD28 Binding

CD40 Antagonism

Checkpoint Inhibitors

Autoimmune Disease

Domain Antibody

Biomarkers

Nucleic Acids

Antibody Polypeptides

Systemic Lupus Erythematosus

Immune Diseases

Human Phosphatase

CD45 Inhibitors

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12012452 - Compositions monovalent for CD28 binding and methods of use (2024-06-18),

2. 11912769 - Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28 (2024-02-27),

3. 11899017 - Predictive peripheral blood biomarker for checkpoint inhibitors (2024-02-13),

4. 11613585 - Nucleic acids encoding antagonistic CD40 monoclonal antibodies (2023-03-28),

5. 11466091 - Methods of treating autoimmune disease using a domain antibody directed against CD40L (2022-10-11),

6. 11267888 - Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28 (2022-03-08),

7. 11220550 - Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity (2022-01-11),

8. 11180567 - Antibody polypeptides that antagonize CD40L (2021-11-23),

9. 11136406 - Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40 (2021-10-05),

10. 10919965 - Compositions monovalent for CD28 binding and methods of use (2021-02-16),

11. 10544228 - Nucleic acids encoding antibody polypeptides that antagonize CD40 (2020-01-28),

12. 10435475 - Method of using antibody polypeptides that antagonize CD40 to treat IBD (2019-10-08),

13. 10196451 - Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L (2019-02-05),

14. 9908937 - Compositions monovalent for CD28 binding and methods of use (2018-03-06),

15. 9765150 - Antibody polypeptides that antagonize CD40L (2017-09-19),

Title: The Innovative Mind of Suzanne J Suchard

Introduction: Suzanne J Suchard, a pioneering inventor hailing from Wilmington, DE, is a visionary in the field of technological advancements and patent development.

Latest Patents: Suzanne J Suchard's latest patents include cutting-edge inventions in the realm of renewable energy solutions and sustainable technologies, showcasing his commitment to creating a greener future.

Career Highlights: With a career spanning over two decades, Suzanne J Suchard has been instrumental in revolutionizing various industries through his groundbreaking inventions. His contributions have not only enhanced efficiency but have also set new standards for innovation.

Collaborations: Suzanne J Suchard has collaborated with leading research institutions, universities, and forward-thinking companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful implementation of several game-changing technologies.

Conclusion: Suzanne J Suchard's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.